Relationship between serum CK-MB-estimated acute myocardial infarct size and clinical complications

Area of Science:

• Cardiology
• Biochemistry

Background:

• Acute myocardial infarct (AMI) size is a critical determinant of patient outcomes.
• Accurate estimation of AMI size is essential for predicting morbidity and mortality.

Purpose of the Study:

• To investigate the relationship between acute myocardial infarct size and subsequent morbidity and mortality.
• To assess the correlation between infarct size and complications such as ventricular arrhythmias, heart failure, and cardiogenic shock.

Main Methods:

• Serum creatine kinase (CK)-MB levels were measured thrice daily to estimate infarct size in 317 patients.
• Patients were followed for one year or until death, with data on ventricular arrhythmias, heart failure, cardiogenic shock, and cardiac performance during exercise collected.
• Hospital and one-year mortality rates were registered.

Main Results:

• A positive correlation was observed between CK-MB-estimated infarct size and the incidence of ventricular arrhythmias (p < 0.05).
• Patients with congestive heart failure and cardiogenic shock had significantly larger infarct sizes (p < 0.05-0.01).
• Exercise test revealed negative correlation between systolic blood pressure rise and positive correlation between heart rate rise with infarct size (p < 0.01).
• Both hospital and one-year mortality were significantly related to estimated infarct size (p < 0.01).

Conclusions:

• Infarct size, estimated via serum CK-MB, is a significant predictor of major complications following AMI.
• Larger infarct sizes are associated with a higher incidence of ventricular arrhythmias, heart failure, cardiogenic shock, and increased mortality.